LitAlert ~~ GeneLit.com

    • Genetic testing and its clinical application in prostate cancer management: Consensus statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.
    • Chiu PKF, Lee EKC, Chan MTY, Chan WHC, Cheung MH, Lam M, Ma ESK, Poon DMC.
    • Front Oncol. 2022 Jun 24;12:962958. doi: 10.3389/fonc.2022.962958.
    • Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1.
    • Saad F, de Bono J, Barthélémy P, Dorff T, Mehra N, Scagliotti G, Stirling A, Machiels JP, Renard V, Maruzzo M, Higano CS, Gurney H, Healy C, Bhattacharyya H, Arondekar B, Niyazov A, Fizazi K.
    • Eur Urol. 2022 Jun 21:S0302-2838(22)02407-1. doi: 10.1016/j.eururo.2022.05.030. Epub ahead of print.
  • LitAlert ~~ GeneLit.com

    • A Japanese case of castration-resistant prostate cancer with BRCA2 and RB1 co-loss and TP53 mutation: a case report.
    • Iwasawa T, Kosaka T, Morita S, Mikami S, Nakamura K, Hongo H, Nishihara H, Oya M.
    • BMC Med Genomics. 2022 Jun 20;15(1):138. doi: 10.1186/s12920-022-01286-w.
    • What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor Rucaparib.
    • Loehr A, Petrylak D, Watkins SP.
    • Front Oncol. 2022 Jun 20;12:951348. doi: 10.3389/fonc.2022.951348.
    • A systematic literature review of the management, oncological outcomes and psychosocial implications of male breast cancer.
    • Rutherford CL, Goodman D, Lannigan A.
    • Eur J Surg Oncol. 2022 Jun 10:S0748-7983(22)00488-7. doi: 10.1016/j.ejso.2022.06.004. Epub ahead of print.
    • Review
  • LitAlert ~~ GeneLit.com

    • Surveillance mammography after treatment for male breast cancer.
    • Yadav S, Sangaralingham L, Payne SR, Giridhar KV, Hieken TJ, Boughey JC, Mutter RW, Hawse JR, Jimenez RE, Freedman RA, Khanani S, Couch FJ, Vachon C, Shah N, Leon-Ferre RA, Ruddy KJ.
    • Breast Cancer Res Treat. 2022 Jun 17. doi: 10.1007/s10549-022-06645-w. Epub ahead of print.
    • Nine Myths About Men and Hereditary Cancer.
    • [No author given]
    • My Gene Counsel. Genetic Journal blog. 2022 Jun 15.
  • LitAlert ~~ GeneLit.com

    • PARP Inhibitors: A New Horizon for Patients with Prostate Cancer.
    • Congregado B, Rivero I, Osmán I, Sáez C, Medina López R.
    • Biomedicines. 2022 Jun 15;10(6):1416. doi: 10.3390/biomedicines10061416.
    • Pilot Study: PARP1 Imaging in Advanced Prostate Cancer.
    • Dehdashti F, Reimers MA, Shoghi KI, Chen DL, Luo J, Rogers B, Pachynski RK, Sreekumar S, Weimholt C, Zhou D.
    • Mol Imaging Biol. 2022 Jun 14. doi: 10.1007/s11307-022-01746-w. Epub ahead of print.
    • Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay.
    • Orlando F, Romanel A, Trujillo B, Sigouros M, Wetterskog D, Quaini O, Leone G, Xiang JZ, Wingate A, Tagawa S, Jayaram A, Linch M; PEACE Consortium, Jamal-Hanjani M, Swanton C, Rubin MA, Wyatt AW, Beltran H, Attard G, Demichelis F.
    • NAR Cancer. 2022 May 27;4(2):zcac016. doi: 10.1093/narcan/zcac016.
    • Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
    • Giri VN, Hartman R, Pritzlaff M, Horton C, Keith SW.
    • JCO Precis Oncol. 2022;6:e2200234. doi: 10.1200/PO.22.00234. Epub 2022 Jun 6.
  • LitAlert ~~ GeneLit.com

        <input type="checkbox" id="idlabel" name="boxset" value="data"/>
        <li>    
            <ul class="reflistitem">
                <li class="reftitle">Germline genetics of prostate cancer.</li>
                <li class="refauth">Khan HM, Cheng HH.</li>
                <li><cite class="refcit">Prostate. 2022 Aug;82 Suppl 1:S3-S12. doi: 10.1002/pros.24340.</cite></li>
            </ul>
            <ul class="pmid">
                <li class="pmidid">PMID: 35657157</li>
                <li class="pmidabs"><a href="https://www.ncbi.nlm.nih.gov/pubmed/35657157" rel="external">PubMed abstract</a></li>
                <li class="sourceabs"><a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/pros.24340" rel="external">Source abstract</a></li>
            </ul>
            <ul class="pmid">
                <li class="reftype">Review</li>
                <li><a href="https://onlinelibrary.wiley.com/doi/10.1002/pros.24340" rel="external">Free Full Text</a></li>
            </ul>
        </li>
    
        <input type="checkbox" id="idlabel" name="boxset" value="data"/>
        <li>    
            <ul class="reflistitem">
                <li class="reftitle">Clinical implications of homologous recombination repair mutations in prostate cancer.</li>
                <li class="refauth">Cresta Morgado P, Mateo J.</li>
                <li><cite class="refcit">Prostate. 2022 Aug;82 Suppl 1:S45-S59. doi: 10.1002/pros.24352.</cite></li>
            </ul>
            <ul class="pmid">
                <li class="pmidid">PMID: 35657156</li>
                <li class="pmidabs"><a href="https://www.ncbi.nlm.nih.gov/pubmed/35657156" rel="external">PubMed abstract</a></li>
                <li class="sourceabs"><a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/pros.24352" rel="external">Source abstract</a></li>
            </ul>
            <ul class="pmid">
                <li class="reftype">Review</li>
                <li><a href="https://onlinelibrary.wiley.com/doi/10.1002/pros.24352" rel="external">Free Full Text</a></li>
            </ul>
        </li>

    LitAlert ~~ GeneLit.com

    • Germline genetics of prostate cancer.
    • Khan HM, Cheng HH.
    • Prostate. 2022 Aug;82 Suppl 1:S3-S12. doi: 10.1002/pros.24340.
    • Clinical implications of homologous recombination repair mutations in prostate cancer.
    • Cresta Morgado P, Mateo J.
    • Prostate. 2022 Aug;82 Suppl 1:S45-S59. doi: 10.1002/pros.24352.
  • LitAlert ~~ GeneLit.com

    • DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries.
    • Abdi B, Basset N, Perrot E, Benderra MA, Khalil A, Oudard S, Blanchet P, Brureau L, Coulet F, Cussenot O, Cancel-Tassin G.
    • Prostate. 2022 Jun 2. doi: 10.1002/pros.24374. Epub ahead of print.
    • The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
    • Liu AJ, Kosiorek HE, Ueberroth BE, Jaeger E, Ledet E, Kendi AT, Tzou K, Quevedo F, Choo R, Moore CN, Ho TH, Singh P, Keole SR, Wong WW, Sartor O, Bryce AH.
    • Prostate. 2022 Jun 2. doi: 10.1002/pros.24375. Epub ahead of print.
    • Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men.
    • Heise M, Jarzemski P, Nowak D, Bak A, Junkiert-Czarnecka A, Pilarska-Deltow M, Borysiak M, Pilarska B, Haus O.
    • Cancer Control. 2022 Jan-Dec [2022 May 31];29:10732748211062342. doi: 10.1177/10732748211062342.